Viewing StudyNCT06469138



Ignite Creation Date: 2024-07-17 @ 11:16 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06469138
Status: COMPLETED
Last Update Posted: 2024-06-21
First Post: 2024-06-17

Brief Title: A Phase 1 Study to Investigate 14C-bemcentinib Following Single Oral Administration in Healthy Male Subjects
Sponsor: BerGenBio ASA
Organization: BerGenBio ASA

Conditions & Keywords Data

Conditions:
Name
Non-Small Cell Lung Cancer
Metastatic Melanoma
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Metastatic Pancreatic Cancer
Glioblastoma
Malignant Mesothelioma
COVID-19
Keywords: